Pancragen 20mg (Bioregulator)

$65.00

Pancragen 20mg is the synthetic Khavinson short-peptide bioregulator derived from pancreatic tissue fractions, for in-vitro pancreatic-cell and metabolic research. Greater than 99 percent HPLC verified.

Peptide Science research editorial team.

Pancragen 20mg (Bioregulator) Overview

Pancragen 20mg from Peptide Science is the synthetic Khavinson short-peptide bioregulator derived from pancreatic tissue fractions, supplied as a lyophilised vial for in-vitro and preclinical pancreatic-cell and metabolic research.

Khavinson Short-Peptide Class Background

Pancragen 20mg (Bioregulator) belongs to the Khavinson short-peptide family, a class of synthetic two-to-four-residue peptides originally derived from bioregulator-fraction extracts of mammalian tissues by V. Kh. Khavinson and colleagues from the 1980s onward. The class is characterised by short sequence length (typically 2 to 4 amino acids), organ-specific source-tissue derivation, and synthetic reconstitution of the original tissue-fraction activity. The full class includes Epithalon (pineal), Cortexin (cerebral cortex), Pinealon (pineal), Vesugen (vascular), and the dozen organ-specific bioregulators in this catalogue.

Pancreatic Bioregulator Research Context

Pancragen is studied in preclinical research for pancreatic-cell signalling pathways and metabolic-research models. The compound is the pancreatic-targeted member of the Khavinson family and supports comparative studies alongside the hepatic-derived Livagen and Ovagen. Browse the broader bioregulator peptide range for related Khavinson short peptides.

Vial Specifications

Pancragen 20mg (Bioregulator) research specifications
Property Value
Compound Pancragen 20mg (Bioregulator)
Class Khavinson short-peptide bioregulator
Source-tissue derivation Pancreatic tissue fraction
Supplied form Lyophilised powder, sealed vial
Strength 20 mg per vial
Purity greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For paired research with the related Khavinson bioregulators targeting adjacent metabolic-pathway organ systems, see Livagen Peptide 20mg.

Reconstitution and Handling

The lyophilised short peptide reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard handling practice cited in Khavinson-tradition research protocols.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.

Reviews

There are no reviews yet.

Be the first to review “Pancragen 20mg (Bioregulator)”

Your email address will not be published. Required fields are marked *

Scroll to Top